METHOD FOR DIAGNOSING SEPTIC PROCESS AND PREDICTING SEPTIC COMPLICATIONS DEVELOPMENT IN CHILDREN

FIELD: medicine. ^ SUBSTANCE: method involves determining plasminogen/plasmin, alpha2-macro-globulin, alpha1-antitripsin content at the first, third, fifth and tenth day. The plasminogen/plasmin level being equal to 66-74 mcmole/l or 100-120 mcmole/l, alpha2-macro-globulin level of 2.7-3.0 mcmole/l,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PROKOPENKO JU.D, KARTASHJAN L.S, ZORIN N.A, CHURLJAEV JU.A
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine. ^ SUBSTANCE: method involves determining plasminogen/plasmin, alpha2-macro-globulin, alpha1-antitripsin content at the first, third, fifth and tenth day. The plasminogen/plasmin level being equal to 66-74 mcmole/l or 100-120 mcmole/l, alpha2-macro-globulin level of 2.7-3.0 mcmole/l, alpha1-antitripsin content of 2.38-3.2 mcmole/l, systemic inflammatory response to purulent infection, light severity degree endotoxicosis is diagnosed and favorable disease outcome is predicted. The plasminogen/plasmin level being equal to 50-65 mcmole/l or 125-160 mcmole/l, alpha2-macro-globulin level of 2.3-2.6 mcmole/l, alpha1-antitripsin content of 3.3-4.0 mcmole/l, sepsis with organ and system dysfunction, moderate severity degree endotoxicosis is diagnosed and septic complication availability and lingering disease development course is predicted. The plasminogen/plasmin level being equal to 39-40 mcmole/l, alpha2-macro-globulin level of 1.58-2.08 mcmole/l, alpha1-antitripsin content of 5.0-6.2 mcmole/l, severe sepsis, septic shock, severe degree endotoxicosis is diagnosed and unfavorable disease outcome is predicted. ^ EFFECT: high accuracy of diagnosis. ^ 5 tbl